Ellie Mae, Inc. (NYSE:ELLI) shares fell -4.10% in last trading session and ended the day at $62.43. ELLI Gross Margin is 68.00% and its has a return on assets of 7.00%. Ellie Mae, Inc. (NYSE:ELLI) quarterly performance is -5.41%.
On 4 February, Ellie Mae® (NYSE:ELLI), announced launch of the Ellie Mae Pro™ consulting partner program, designed to accelerate the adoption of Ellie Mae’s Encompass all-in-one mortgage management solution. The Ellie Mae Pro Consulting Partners program offers consulting firms the opportunity to provide a broad range of high-quality services by partnering with Ellie Mae and their customers on Encompass implementations. Through Ellie Mae Pro, consulting partners will be offered training and certification opportunities, along with deeper access to Ellie Mae resources, all designed to ensure customers receive exceptional consulting services.
Fidelity National Financial, Inc. (NYSE:FNF) ended the last trading day at $29.58. Company weekly volatility is calculated as 2.51% and price to cash ratio as 8.71. Fidelity National Financial, Inc. (NYSE:FNF) showed a weekly performance of -8.98%.
Fidelity National Financial, Inc. (NYSE:FNF) announced that its Board of Directors has declared an FNF Group (FNF) quarterly cash dividend of $0.21 per share. The dividend will be payable March 31, 2016, to stockholders of record as of March 17, 2016.
On 08 February, Bonanza Creek Energy, Inc. (NYSE:BCEI) shares fell -14.44% and was closed at $2.31. BCEI EPS growth in last 5 year was 15.90%. Bonanza Creek Energy, Inc. (NYSE:BCEI) year to date (YTD) performance is -56.17%.
Bonanza Creek Energy, Inc. (NYSE:BCEI) continues to work towards closing the sale of its wholly-owned midstream subsidiary, Rocky Mountain Infrastructure, LLC, to Meritage Midstream Services IV, LLC, backed by private equity firm Riverstone Holdings LLC. The parties have mutually agreed to extend the closing date for the transaction to February 29, 2016.
EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) shares fell -15.09% in last trading session and ended the day at $2.70. EPRS has a return on assets of -59.50%. EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS) quarterly performance is -46.43%.
EPIRUS Biopharmaceuticals, Inc. (NASDAQ:EPRS), announced it will participate in multiple panel discussions at the 4th Annual Bloomberg Intelligence Healthcare Event on Friday, Feb. 12. The panels will begin at 1:30 pm ET and focus on the evolving strategies for biosimilars, as well as provide legal and regulatory updates on biosimilars.
Deutsche Bank AG (NYSE:DB) caters to the Financial space. It has a net profit margin of -21.10% and weekly performance is -12.89%. On the last day of trading company shares ended up at $15.54. Deutsche Bank AG (NYSE:DB) distance from 50-day simple moving average (SMA50) is -30.40%.
Deutsche Bank AG (NYSE:DB) Says publishes updated information about AT1 payment capacity. 2016 payment capacity sufficient to pay AT1 coupons of about eur 0.35 billion on 30 April 2016. estimated pro-forma 2017 payment capacity is approximately eur 4.3 billion before impact from 2016 operating results.
Leave a Reply